CVS on Tuesday raised its 2021 earnings forecast, citing higher demand for COVID-19 vaccinations and over-the-counter testing as infections in the US soared due to the fast-spreading Omicron variant. Shares in the drugstore chain operator were up nearly 1% at $106.10 just before noon. The company said it now expects adjusted profit per share for 2021 in the range of $8.33 to $8.38, up from a prior forecast of $8. Higher-than-expected coronavirus vaccinations in November and December, as well as elevated demand for over-the-counter COVID-19 testing in the last month of 2021, helped with a strong retail segment performance, CVS said. Rival Walgreens Boots Alliance last week raised its full-year adjusted profit growth forecast on the back of similar comments. CVS also said its health insurance unit performed better than expected despite higher coronavirus cases, particularly in the back half of the fourth quarter, as deferred elective procedures offset higher COVID-19 costs.
You May Also Like
Business
Activist investor Starboard Value has purchased a 6.5% stake in web services firm GoDaddy worth about $800 million, according to a regulatory filing with...
Business
Contact The Author Female employees at CNN are furious that chief spokesperson Allison Gollust is keeping her job after lying about her affair with...
Business
North Korean hackers managed to steal a fortune in cryptocurrency in 2021, according to the results of a recent study. Cybercriminals based in North...
Finance
For the best part of a decade, rock-bottom interest rates seemed like a fact of life in the euro zone—as did low inflation. Now...